Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity do not respond as strongly ...

“Dr. Chen Chih-jung of Linkou Chang Gung Memorial Hospital stated in an interview on Thursday that hMPV is similar to ...

Zelpultide alfa is under clinical development by Airway Therapeutics and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

Approximately 40% of participants did not seroconvert or achieve a conservative neutralization threshold post-vaccination.

ASC-60 is under clinical development by Sagimet Biosciences and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate ...

Scanning electron micrograph of human respiratory syncytial virus (RSV) virions (colorized blue) and tagged with antibodies (colorized yellow) against the virus’ fusion protein — the target of RSV ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The S&P 600 small-cap index saw stocks giving returns of over 280%. Check out the top five performers in the index.

Respiratory illness activity – a measure of how often conditions like the common cold, flu, COVID-19, and respiratory ...

Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity—primarily organ transplant ...

Feeling ill after that Christmas or New Year's Eve party? If could be RSV. But how can you know for sure? Here are the ...

Americans can prevent the spread of viruses in several ways, such as staying home when they feel sick or properly washing ...